{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:41:38Z","timestamp":1793043698165,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chinese Research Hospital Association","award":["Y2023FH-TTYGJZA11"],"award-info":[{"award-number":["Y2023FH-TTYGJZA11"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171208"],"award-info":[{"award-number":["82171208"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2508703, 2023YFC2508700"],"award-info":[{"award-number":["2023YFC2508703, 2023YFC2508700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Migraine stands as a prevalent primary headache disorder, with prior research highlighting the significant involvement of oxidative stress and inflammatory pathways in its pathogenesis and chronicity. Existing evidence indicates the capacity of Dl-3-n-butylphthalide (NBP) to mitigate oxidative stress and inflammation, thereby conferring neuroprotective benefits in many central nervous system diseases. However, the specific therapeutic implications of NBP in the context of migraine remain to be elucidated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We established a C57BL\/6 mouse model of chronic migraine (CM) using recurrent intraperitoneal injections of nitroglycerin (NTG, 10\u00a0mg\/kg), and prophylactic treatment was simulated by administering NBP (30\u00a0mg\/kg, 60\u00a0mg\/kg, 120\u00a0mg\/kg) by gavage prior to each NTG injection. Mechanical threshold was assessed using von Frey fibers, and photophobia and anxious behaviours were assessed using a light\/dark box and elevated plus maze. Expression of c-Fos, calcitonin gene-related peptide (CGRP), Nucleus factor erythroid 2-related factor 2 (Nrf2) and related pathway proteins in the spinal trigeminal nucleus caudalis (SP5C) were detected by Western blotting (WB) or immunofluorescence (IF). The expression of IL-1\u03b2, IL-6, TNF-\u03b1, Superoxide dismutase (SOD) and malondialdehyde (MDA) in SP5C and CGRP in plasma were detected by ELISA. A reactive oxygen species (ROS) probe was used to detect the expression of ROS in the SP5C.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>At the end of the modelling period, chronic migraine mice showed significantly reduced mechanical nociceptive thresholds, as well as photophobic and anxious behaviours. Pretreatment with NBP attenuated nociceptive sensitization, photophobia, and anxiety in the model mice, reduced expression levels of c-Fos and CGRP in the SP5C and activated Nrf2 and its downstream proteins HO-1 and NQO-1. By measuring the associated cytokines, we also found that NBP reduced levels of oxidative stress and inflammation. Most importantly, the therapeutic effect of NBP was significantly reduced after the administration of ML385 to inhibit Nrf2.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our data suggest that NBP may alleviate migraine by activating the Nrf2 pathway to reduce oxidative stress and inflammation in migraine mouse models, confirming that it may be a potential drug for the treatment of migraine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s10194-024-01750-1","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T09:02:24Z","timestamp":1712048544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Unveiling the therapeutic potential of Dl-3-n-butylphthalide in NTG-induced migraine mouse: activating the Nrf2 pathway to alleviate oxidative stress and neuroinflammation"],"prefix":"10.1186","volume":"25","author":[{"given":"Yingyuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihua","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqi","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangshuang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8933-088X","authenticated-orcid":false,"given":"Shengyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4581-2569","authenticated-orcid":false,"given":"Zhao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"key":"1750_CR1","first-page":"g1416","volume":"348","author":"TJ Schwedt","year":"2014","unstructured":"Schwedt TJ (2014) Chronic migraine. BMJ (Clinical Research ed) 348:g1416","journal-title":"BMJ (Clinical Research ed)"},{"key":"1750_CR2","first-page":"e067670","volume":"379","author":"A Hovaguimian","year":"2022","unstructured":"Hovaguimian A, Roth J (2022) Management of chronic migraine. BMJ (Clinical Research ed) 379:e067670","journal-title":"BMJ (Clinical Research ed)"},{"key":"1750_CR3","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMra1915327","volume":"383","author":"M Ashina","year":"2020","unstructured":"Ashina M (2020) Migraine. N Engl J Med 383:1866\u20131876","journal-title":"N Engl J Med"},{"key":"1750_CR4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1136\/jnnp-2016-313458","volume":"87","author":"AL Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves AL, Martini Ferreira A, Ribeiro RT, Zukerman E, Cipolla-Neto J, Peres MFP (2016) Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. J Neurol Neurosurg Psychiatry 87:1127\u20131132","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1750_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2165\/00003495-198427010-00002","volume":"27","author":"B Holmes","year":"1984","unstructured":"Holmes B, Brogden RN, Heel RC, Speight TM, Avery GS (1984) Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs 27:6\u201344","journal-title":"Drugs"},{"key":"1750_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-021-00509-5","volume":"17","author":"AK Eigenbrodt","year":"2021","unstructured":"Eigenbrodt AK, Ashina H, Khan S, Diener H-C, Mitsikostas DD, Sinclair AJ, Pozo-Rosich P, Martelletti P, Ducros A, Lant\u00e9ri-Minet M et al (2021) Diagnosis and management of migraine in ten steps. Nat Rev Neurol 17:501\u2013514","journal-title":"Nat Rev Neurol"},{"key":"1750_CR7","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/S0140-6736(20)32162-0","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Terwindt GM, Al-Karagholi MAM, de Boer I, Lee MJ, Hay DL, Schulte LH, Hadjikhani N, Sinclair AJ, Ashina H et al (2021) Migraine: disease characterisation, biomarkers, and precision medicine. Lancet (London, England) 397:1496\u20131504","journal-title":"Lancet (London, England)"},{"key":"1750_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrneurol.2010.127","volume":"6","author":"TW Ho","year":"2010","unstructured":"Ho TW, Edvinsson L, Goadsby PJ (2010) CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol 6:573\u2013582","journal-title":"Nat Rev Neurol"},{"key":"1750_CR9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","volume":"14","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L, Haanes KA, Warfvinge K, Krause DN (2018) CGRP as the target of new migraine therapies - successful translation from bench to clinic. Nat Rev Neurol 14:338\u2013350","journal-title":"Nat Rev Neurol"},{"key":"1750_CR10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41582-019-0255-4","volume":"15","author":"EC Gross","year":"2019","unstructured":"Gross EC, Lisicki M, Fischer D, S\u00e1ndor PS, Schoenen J (2019) The metabolic face of migraine - from pathophysiology to treatment. Nat Rev Neurol 15:627\u2013643","journal-title":"Nat Rev Neurol"},{"key":"1750_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00281-018-0676-y","volume":"40","author":"R Ramachandran","year":"2018","unstructured":"Ramachandran R (2018) Neurogenic inflammation and its role in migraine. Seminars In Immunopathology 40:301\u2013314","journal-title":"Seminars In Immunopathology"},{"key":"1750_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/0960327112459204","volume":"32","author":"S Vurucu","year":"2013","unstructured":"Vurucu S, Karaoglu A, Paksu MS, Yesilyurt O, Oz O, Unay B, Akin R (2013) Relationship between oxidative stress and chronic daily headache in children. Hum Exp Toxicol 32:113\u2013119","journal-title":"Hum Exp Toxicol"},{"key":"1750_CR13","doi-asserted-by":"publisher","first-page":"e35677","DOI":"10.1371\/journal.pone.0035677","volume":"7","author":"MD Cordero","year":"2012","unstructured":"Cordero MD, Cano-Garc\u00eda FJ, Alcocer-G\u00f3mez E, De Miguel M, S\u00e1nchez-Alc\u00e1zar JA (2012) Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q10 effect on clinical improvement. PLoS ONE 7:e35677","journal-title":"PLoS ONE"},{"key":"1750_CR14","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.clineuro.2012.08.028","volume":"115","author":"M Neyal","year":"2013","unstructured":"Neyal M, Yimenicioglu F, Aydeniz A, Taskin A, Saglam S, Cekmen M, Neyal A, Gursoy S, Erel O, Balat A (2013) Plasma nitrite levels, total antioxidant status, total oxidant status, and oxidative stress index in patients with tension-type headache and fibromyalgia. Clin Neurol Neurosurg 115:736\u2013740","journal-title":"Clin Neurol Neurosurg"},{"key":"1750_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12011-008-8193-9","volume":"126","author":"D Tuncel","year":"2008","unstructured":"Tuncel D, Tolun FI, Gokce M, Imrek S, Ekerbi\u00e7er H (2008) Oxidative stress in migraine with and without aura. Biol Trace Elem Res 126:92\u201397","journal-title":"Biol Trace Elem Res"},{"key":"1750_CR16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s13760-015-0427-y","volume":"115","author":"Y Eren","year":"2015","unstructured":"Eren Y, Dirik E, Ne\u015felio\u011flu S, Erel \u00d6 (2015) Oxidative stress and decreased thiol level in patients with migraine: cross-sectional study. Acta Neurol Belg 115:643\u2013649","journal-title":"Acta Neurol Belg"},{"key":"1750_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1023\/B:MCBI.0000049134.69131.89","volume":"266","author":"M Valko","year":"2004","unstructured":"Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J (2004) Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 266:37\u201356","journal-title":"Mol Cell Biochem"},{"key":"1750_CR18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.pain.2007.01.011","volume":"131","author":"X Gao","year":"2007","unstructured":"Gao X, Kim HK, Mo Chung J, Chung K (2007) Reactive oxygen species (ROS) are involved in enhancement of NMDA-receptor phosphorylation in animal models of pain. Pain 131:262\u2013271","journal-title":"Pain"},{"key":"1750_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.pain.2004.06.008","volume":"111","author":"HK Kim","year":"2004","unstructured":"Kim HK, Park SK, Zhou J-L, Taglialatela G, Chung K, Coggeshall RE, Chung JM (2004) Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain 111:116\u2013124","journal-title":"Pain"},{"key":"1750_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrn3617","volume":"15","author":"DN Xanthos","year":"2014","unstructured":"Xanthos DN, Sandk\u00fchler J (2014) Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity. Nat Rev Neurosci 15:43\u201353","journal-title":"Nat Rev Neurosci"},{"key":"1750_CR21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41582-019-0216-y","volume":"15","author":"L Edvinsson","year":"2019","unstructured":"Edvinsson L, Haanes KA, Warfvinge K (2019) Does inflammation have a role in migraine? Nat Rev Neurol 15:483\u2013490","journal-title":"Nat Rev Neurol"},{"key":"1750_CR22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1146\/annurev-pharmtox-010818-021856","volume":"59","author":"M Dodson","year":"2019","unstructured":"Dodson M, de la Vega MR, Cholanians AB, Schmidlin CJ, Chapman E, Zhang DD (2019) Modulating NRF2 in disease: timing is everything. Annu Rev Pharmacol Toxicol 59:555\u2013575","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1750_CR23","doi-asserted-by":"publisher","first-page":"11624","DOI":"10.1038\/ncomms11624","volume":"7","author":"EH Kobayashi","year":"2016","unstructured":"Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Hayashi M, Sekine H, Tanaka N, Moriguchi T, Motohashi H, Nakayama K, Yamamoto M (2016) Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat Commun 7:11624","journal-title":"Nat Commun"},{"key":"1750_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pharmthera.2015.11.003","volume":"157","author":"I Buendia","year":"2016","unstructured":"Buendia I, Michalska P, Navarro E, Gameiro I, Egea J, Le\u00f3n R (2016) Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacol Ther 157:84\u2013104","journal-title":"Pharmacol Ther"},{"key":"1750_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s10194-016-0694-x","volume":"17","author":"W Di","year":"2016","unstructured":"Di W, Shi X, Lv H, Liu J, Zhang H, Li Z, Fang Y (2016) Activation of the nuclear factor E2-related factor 2\/anitioxidant response element alleviates the nitroglycerin-induced hyperalgesia in rats. J Headache Pain 17:99","journal-title":"J Headache Pain"},{"key":"1750_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12974-020-01736-1","volume":"17","author":"G Casili","year":"2020","unstructured":"Casili G, Lanza M, Filippone A, Campolo M, Paterniti I, Cuzzocrea S, Esposito E (2020) Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice. J Neuroinflammation 17:59","journal-title":"J Neuroinflammation"},{"key":"1750_CR27","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.3760\/cma.j.issn.0366-6999.20123240","volume":"126","author":"L-Y Cui","year":"2013","unstructured":"Cui L-Y, Zhu Y-C, Gao S, Wang J-M, Peng B, Ni J, Zhou L-X, He J, Ma X-Q (2013) Ninety-day administration of dl-3-n-butylphthalide for acute ischemic stroke: a randomized, double-blind trial. Chin Med J 126:3405\u20133410","journal-title":"Chin Med J"},{"key":"1750_CR28","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s00213-018-4949-x","volume":"235","author":"M Yang","year":"2018","unstructured":"Yang M, Dang R, Xu P, Guo Y, Han W, Liao D, Jiang P (2018) Dl-3-n-Butylphthalide improves lipopolysaccharide-induced depressive-like behavior in rats: involvement of Nrf2 and NF-\u03baB pathways. Psychopharmacology 235:2573\u20132585","journal-title":"Psychopharmacology"},{"key":"1750_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.18632\/aging.204481","volume":"15","author":"J He","year":"2023","unstructured":"He J, Gao J, Zhu H, Zhao Y, Zhang X, Wang X, Wan S, Cao H, Zhai L, Wang Y, Wang S (2023) Effects of NBP on postoperative cognitive dysfunction in rats via Nrf 2\/ARE pathway. Aging 15:276\u2013286","journal-title":"Aging"},{"key":"1750_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12974-021-02342-5","volume":"18","author":"Q Wen","year":"2021","unstructured":"Wen Q, Wang Y, Pan Q, Tian R, Zhang D, Qin G, Zhou J, Chen L (2021) MicroRNA-155-5p promotes neuroinflammation and central sensitization via inhibiting SIRT1 in a nitroglycerin-induced chronic migraine mouse model. J Neuroinflammation 18:287","journal-title":"J Neuroinflammation"},{"key":"1750_CR31","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.7150\/thno.33872","volume":"9","author":"P Xian","year":"2019","unstructured":"Xian P, Hei Y, Wang R, Wang T, Yang J, Li J, Di Z, Liu Z, Baskys A, Liu W et al (2019) Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice. Theranostics 9:5956\u20135975","journal-title":"Theranostics"},{"key":"1750_CR32","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1021\/acschembio.6b00651","volume":"11","author":"A Singh","year":"2016","unstructured":"Singh A, Venkannagari S, Oh KH, Zhang Y-Q, Rohde JM, Liu L, Nimmagadda S, Sudini K, Brimacombe KR, Gajghate S et al (2016) Small Molecule Inhibitor of NRF2 Selectively Intervenes therapeutic resistance in KEAP1-deficient NSCLC tumors. ACS Chem Biol 11:3214\u20133225","journal-title":"ACS Chem Biol"},{"key":"1750_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.pain.2013.10.004","volume":"155","author":"AA Pradhan","year":"2014","unstructured":"Pradhan AA, Smith ML, McGuire B, Tarash I, Evans CJ, Charles A (2014) Characterization of a novel model of chronic migraine. Pain 155:269\u2013274","journal-title":"Pain"},{"key":"1750_CR34","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.nbd.2011.10.010","volume":"45","author":"A Markovics","year":"2012","unstructured":"Markovics A, Kormos V, Gaszner B, Lashgarara A, Szoke E, Sandor K, Szabadfi K, Tuka B, Tajti J, Szolcsanyi J et al (2012) Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice. Neurobiol Dis 45:633\u2013644","journal-title":"Neurobiol Dis"},{"key":"1750_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/brain\/awy313","volume":"142","author":"S Akerman","year":"2019","unstructured":"Akerman S, Karsan N, Bose P, Hoffmann JR, Holland PR, Romero-Reyes M, Goadsby PJ (2019) Nitroglycerine triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity. Brain 142:103\u2013119","journal-title":"Brain"},{"key":"1750_CR36","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1093\/brain\/awt251","volume":"136","author":"MA Louter","year":"2013","unstructured":"Louter MA, Bosker JE, van Oosterhout WPJ, van Zwet EW, Zitman FG, Ferrari MD, Terwindt GM (2013) Cutaneous allodynia as a predictor of migraine chronification. Brain 136:3489\u20133496","journal-title":"Brain"},{"key":"1750_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/ana.25926","volume":"89","author":"AM Harriott","year":"2021","unstructured":"Harriott AM, Chung DY, Uner A, Bozdayi RO, Morais A, Takizawa T, Qin T, Ayata C (2021) Optogenetic spreading depression elicits trigeminal pain and anxiety behavior. Ann Neurol 89:99\u2013110","journal-title":"Ann Neurol"},{"key":"1750_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s10194-017-0718-1","volume":"18","author":"S Seidel","year":"2017","unstructured":"Seidel S, Beisteiner R, Manecke M, Aslan TS, W\u00f6ber C (2017) Psychiatric comorbidities and photophobia in patients with migraine. J Headache Pain 18:18","journal-title":"J Headache Pain"},{"key":"1750_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jneumeth.2017.04.010","volume":"284","author":"HM Harris","year":"2017","unstructured":"Harris HM, Carpenter JM, Black JR, Smitherman TA, Sufka KJ (2017) The effects of repeated nitroglycerin administrations in rats; modeling migraine-related endpoints and chronification. J Neurosci Methods 284:63\u201370","journal-title":"J Neurosci Methods"},{"key":"1750_CR40","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1007\/s00415-022-11080-4","volume":"269","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang S, Qiu T, Xiao Z (2022) Photophobia in headache disorders: characteristics and potential mechanisms. J Neurol 269:4055\u20134067","journal-title":"J Neurol"},{"key":"1750_CR41","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/jnnp-2015-312233","volume":"87","author":"MT Minen","year":"2016","unstructured":"Minen MT, Begasse De Dhaem O, Kroon Van Diest A, Powers S, Schwedt TJ, Lipton R, Silbersweig D (2016) Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry 87:741\u2013749","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1750_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12974-022-02400-6","volume":"19","author":"R Dang","year":"2022","unstructured":"Dang R, Wang M, Li X, Wang H, Liu L, Wu Q, Zhao J, Ji P, Zhong L, Licinio J, Xie P (2022) Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1\/Nrf2\/HO-1\/Gpx4 pathway. J Neuroinflammation 19:41","journal-title":"J Neuroinflammation"},{"key":"1750_CR43","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/head.13529","volume":"59","author":"S Iyengar","year":"2019","unstructured":"Iyengar S, Johnson KW, Ossipov MH, Aurora SK (2019) CGRP and the trigeminal system in migraine. Headache 59:659\u2013681","journal-title":"Headache"},{"key":"1750_CR44","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/j.pain.0000000000001124","volume":"159","author":"PE Kunkler","year":"2018","unstructured":"Kunkler PE, Zhang L, Johnson PL, Oxford GS, Hurley JH (2018) Induction of chronic migraine phenotypes in a rat model after environmental irritant exposure. Pain 159:540\u2013549","journal-title":"Pain"},{"key":"1750_CR45","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12974-019-1459-7","volume":"16","author":"W He","year":"2019","unstructured":"He W, Long T, Pan Q, Zhang S, Zhang Y, Zhang D, Qin G, Chen L, Zhou J (2019) Microglial NLRP3 inflammasome activation mediates IL-1\u03b2 release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model. J Neuroinflammation 16:78","journal-title":"J Neuroinflammation"},{"key":"1750_CR46","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.3390\/nu13124433","volume":"13","author":"M Fila","year":"2021","unstructured":"Fila M, Chojnacki C, Chojnacki J, Blasiak J (2021) Nutrients ine. Nutrients 13:4433","journal-title":"Nutrients"},{"key":"1750_CR47","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s10194-015-0516-6","volume":"16","author":"C Gaul","year":"2015","unstructured":"Gaul C, Diener H-C, Danesch U (2015) Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-Controlled, double-blind, multicenter trial. J Headache Pain 16:516","journal-title":"J Headache Pain"},{"key":"1750_CR48","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","volume":"18","author":"M Ashina","year":"2019","unstructured":"Ashina M, Hansen JM, Do TP, Melo-Carrillo A, Burstein R, Moskowitz MA (2019) Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol 18:795\u2013804","journal-title":"Lancet Neurol"},{"key":"1750_CR49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s10194-022-01449-1","volume":"23","author":"R Greco","year":"2022","unstructured":"Greco R, Demartini C, Zanaboni AM, Francavilla M, Reggiani A, Realini N, Scarpelli R, Piomelli D, Tassorelli C (2022) Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine. J Headache Pain 23:79","journal-title":"J Headache Pain"},{"key":"1750_CR50","doi-asserted-by":"publisher","first-page":"e2038","DOI":"10.1212\/WNL.0000000000007371","volume":"92","author":"DS Albrecht","year":"2019","unstructured":"Albrecht DS, Mainero C, Ichijo E, Ward N, Granziera C, Z\u00fcrcher NR, Akeju O, Bonnier G, Price J, Hooker JM et al (2019) Imaging of neuroinflammation in migraine with aura: a [11C]PBR28 PET\/MRI study. Neurology 92:e2038\u2013e2050","journal-title":"Neurology"},{"key":"1750_CR51","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1089\/ars.2017.7440","volume":"30","author":"C-Y Wang","year":"2019","unstructured":"Wang C-Y, Xu Y, Wang X, Guo C, Wang T, Wang Z-Y (2019) Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer\u2019s-Like pathology via Nrf2-TXNIP-TrX Axis. Antioxid Redox Signal 30:1411\u20131431","journal-title":"Antioxid Redox Signal"},{"key":"1750_CR52","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.neuropharm.2011.10.009","volume":"62","author":"X Feng","year":"2012","unstructured":"Feng X, Peng Y, Liu M, Cui L (2012) DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis. Neuropharmacology 62:1004\u20131010","journal-title":"Neuropharmacology"},{"key":"1750_CR53","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.3390\/molecules25225474","volume":"25","author":"S Saha","year":"2020","unstructured":"Saha S, Buttari B, Panieri E, Profumo E, Saso L (2020) An overview of Nrf2 signaling pathway and its role in inflammation. Molecules (Basel, Switzerland) 25:5474","journal-title":"Molecules (Basel, Switzerland)"},{"key":"1750_CR54","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.3390\/ijms21134777","volume":"21","author":"F He","year":"2020","unstructured":"He F, Ru X, Wen T (2020) NRF2, a transcription factor for stress response and beyond. Int J Mol Sci 21:4777","journal-title":"Int J Mol Sci"},{"key":"1750_CR55","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1002\/cam4.5311","volume":"12","author":"L Ji","year":"2023","unstructured":"Ji L, Moghal N, Zou X, Fang Y, Hu S, Wang Y, Tsao MS (2023) The NRF2 antagonist ML385 inhibits PI3K-mTOR signaling and growth of lung squamous cell carcinoma cells. Cancer Med 12:5688\u20135702","journal-title":"Cancer Med"},{"key":"1750_CR56","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41401-020-00583-3","volume":"42","author":"B-N Wang","year":"2021","unstructured":"Wang B-N, Wu C-B, Chen Z-M, Zheng P-P, Liu Y-Q, Xiong J, Xu J-Y, Li P-F, Mamun AA, Ye L-B et al (2021) DL-3-n-butylphthalide ameliorates diabetes-associated cognitive decline by enhancing PI3K\/Akt signaling and suppressing oxidative stress. Acta Pharmacol Sin 42:347\u2013360","journal-title":"Acta Pharmacol Sin"},{"key":"1750_CR57","doi-asserted-by":"publisher","first-page":"794770","DOI":"10.3389\/fimmu.2021.794770","volume":"12","author":"R Que","year":"2021","unstructured":"Que R, Zheng J, Chang Z, Zhang W, Li H, Xie Z, Huang Z, Wang H-T, Xu J, Jin D et al (2021) Dl-3-n-Butylphthalide rescues dopaminergic neurons in parkinson\u2019s disease models by inhibiting the NLRP3 inflammasome and ameliorating mitochondrial impairment. Front Immunol 12:794770","journal-title":"Front Immunol"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-024-01750-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T10:02:02Z","timestamp":1712052122000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-024-01750-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1750"],"URL":"https:\/\/doi.org\/10.1186\/s10194-024-01750-1","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,2]]},"assertion":[{"value":"15 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved by the Institutional Animal Care and Use Committee of the Chinese People's Liberation Army (PLA) General Hospital, and animal experiments were conducted according to the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}